Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP978546.RA99YaAjovFV0S1YpTJ8Z0zcx4W4rYVU-mC-pi7pSctps130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP978546.RA99YaAjovFV0S1YpTJ8Z0zcx4W4rYVU-mC-pi7pSctps130_assertion type Assertion NP978546.RA99YaAjovFV0S1YpTJ8Z0zcx4W4rYVU-mC-pi7pSctps130_head.
- NP978546.RA99YaAjovFV0S1YpTJ8Z0zcx4W4rYVU-mC-pi7pSctps130_assertion description "[With the advent of targeted signal transduction therapy, patients with rearrangement of PDGFRB might be better classified as a distinct subgroup of MPD/MDS.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP978546.RA99YaAjovFV0S1YpTJ8Z0zcx4W4rYVU-mC-pi7pSctps130_provenance.
- NP978546.RA99YaAjovFV0S1YpTJ8Z0zcx4W4rYVU-mC-pi7pSctps130_assertion evidence source_evidence_literature NP978546.RA99YaAjovFV0S1YpTJ8Z0zcx4W4rYVU-mC-pi7pSctps130_provenance.
- NP978546.RA99YaAjovFV0S1YpTJ8Z0zcx4W4rYVU-mC-pi7pSctps130_assertion SIO_000772 11919393 NP978546.RA99YaAjovFV0S1YpTJ8Z0zcx4W4rYVU-mC-pi7pSctps130_provenance.
- NP978546.RA99YaAjovFV0S1YpTJ8Z0zcx4W4rYVU-mC-pi7pSctps130_assertion wasDerivedFrom befree-20150227 NP978546.RA99YaAjovFV0S1YpTJ8Z0zcx4W4rYVU-mC-pi7pSctps130_provenance.
- NP978546.RA99YaAjovFV0S1YpTJ8Z0zcx4W4rYVU-mC-pi7pSctps130_assertion wasGeneratedBy ECO_0000203 NP978546.RA99YaAjovFV0S1YpTJ8Z0zcx4W4rYVU-mC-pi7pSctps130_provenance.